BIT Capital’s Ascendis Pharma A/S ASND Stock Holding History

BIT Capital’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-73,990	Closed	-$10.2M	–	114
2024 Q4	$10.2M	Buy	73,990 +5,569	+8%	+$732K	0.81%	22
2024 Q3	$10.2M	Sell	68,421 -36,217	-35%	-$4.89M	0.95%	22
2024 Q2	$14.3M	Sell	104,638 -5,000	-5%	-$680K	1.12%	25
2024 Q1	$16.6M	Buy	109,638 +48,108	+78%	+$6.87M	1.23%	22
2023 Q4	$7.75M	Buy	61,530 +52,407	+574%	+$5.22M	0.76%	29
2023 Q3	$854K	Hold	9,123	–	–	0.1%	60
2023 Q2	$814K	Buy	9,123 +1,700	+23%	+$148K	0.08%	80
2023 Q1	$796K	Buy	7,423 +445	+6%	+$50.9K	0.12%	76
2022 Q4	$852K	Buy	6,978 +2,249	+48%	+$261K	0.17%	45
2022 Q3	$488K	Buy	4,729 +3,929	+491%	+$373K	0.09%	69
2022 Q2	$74.4K	Hold	800	–	–	0.01%	102
2022 Q1	$93.9K	Buy	+800	New	+$92.7K	0.01%	106

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIT Capital's ASND Position: Q1 2025 in Review

BIT Capital sold out of Ascendis Pharma A/S (ASND) in Q1 2025, closing a stake of 73,990 shares — an estimated $10.2M sold.

BIT Capital first reported a position in ASND in Q1 2022 and held it in 12 quarters. The position peaked at $16.6M in Q1 2024. 244 funds tracked by Wall St. Rank hold ASND as of Q1 2025.

BIT Capital reported no remaining Ascendis Pharma A/S position as of Q1 2025 after selling out during the quarter.
BIT Capital sold 73,990 Ascendis Pharma A/S shares in Q1 2025, an estimated $10.2M.
BIT Capital first reported a position in Ascendis Pharma A/S in Q1 2022 and held it in 12 quarters.
BIT Capital's Ascendis Pharma A/S position peaked at $16.6M in Q1 2024.
244 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2025.

Based on BIT Capital's 13F filing for Q1 2025, filed 9 May 2025.